Heart Failure

Persistent mortality and heart failure burden of anterior ST-segment elevation myocardial infarction following primary percutaneous coronary intervention: real-world evidence from the US Medicare Data Set
Jack Martin

BMJ Open Jun 2023, 13 (6) e070210; DOI: 10.1136/bmjopen-2022-070210
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study
Zubaid Rafique, Jeffrey Budden, Carol Moreno Quinn, Youyou Duanmu, Basmah Safdar, Jason J Bischof, Brian E Driver, Charles A Herzog, Matthew R Weir, Adam J Singer, Stephen Boone, Karina M Soto-Ruiz, W Frank Peacock

BMJ Open Jun 2023, 13 (6) e071311; DOI: 10.1136/bmjopen-2022-071311
In-hospital therapies and determinants of treatment strategy selection in patients with atrial fibrillation and left ventricular systolic dysfunction in China: a retrospective study based on the Improving Care for Cardiovascular Disease in China-Atrial Fibrillation (CCC-AF) project, 2015–2019
Pengkang He, Yannan Pan, Jie Jiang, Fangfang Fan, Jing Zhou, Yulong Xia, Jun Liu, Na Yang, Yongchen Hao, Jianping Li, Jing Liu, Dong Zhao, Yong Huo

BMJ Open Jun 2023, 13 (6) e070070; DOI: 10.1136/bmjopen-2022-070070
Protocol for a systematic review and meta-analysis assessing conservative versus liberal intravenous fluid administration in patients with sepsis or septic shock at risk of fluid overload
Aadil Bharwani, María Lucía Pérez, Marina Englesakis, Tine Sylvest Meyhoff, Anders Perner, Praleene Sivapalan, Mary Elizabeth Wilcox

BMJ Open May 2023, 13 (5) e069601; DOI: 10.1136/bmjopen-2022-069601
Evaluation of health utility in trial-based cost–utility analyses for major cardiovascular disease: protocol for a systematic review
Yasuhisa Nakao, Hiroshi Kawakami, Shigehiro Miyazaki, Makoto Saito, Yan Luo, Kazumichi Yamamoto, Osamu Yamaguchi

BMJ Open May 2023, 13 (5) e067045; DOI: 10.1136/bmjopen-2022-067045
Outcomes of discontinuing renin-angiotensin system inhibitors: a study protocol for conducting systematic review and meta-analysis
Taihei Suzuki, Hiroki Nishiwaki, Yoshitaka Watanabe, Yoshifusa Abe, Hisashi Noma, Erika Ota, Hirokazu Honda, Takeshi Hasegawa

BMJ Open May 2023, 13 (5) e070345; DOI: 10.1136/bmjopen-2022-070345
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case–control study
Viveca Ritsinger, Johan Bodegård, Robin Kristofi, Marcus Thuresson, David Nathanson, Thomas Nyström, Jan Eriksson, Anna Norhammar

BMJ Open Apr 2023, 13 (4) e069037; DOI: 10.1136/bmjopen-2022-069037
Protocol for a realist and social return on investment evaluation of the use of patient-reported outcomes in four value-based healthcare programmes
Gareth Roberts, Adele Cahill, Charlotte Lawthom, Martine Price, Christopher Blyth, Carys Jones, Leah Mc Laughlin, Jane Noyes

BMJ Open Apr 2023, 13 (4) e072234; DOI: 10.1136/bmjopen-2023-072234
Population-based assessment of cardiovascular complications of rheumatic heart disease in Fiji: a record-linkage analysis
Tom Parks, Litia Narube, Mai Ling Perman, Kelera Sakumeni, James J Fong, Daniel Engelman, Samantha M Colquhoun, Andrew C Steer, Joseph Kado

BMJ Open Apr 2023, 13 (4) e070629; DOI: 10.1136/bmjopen-2022-070629
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study
Efe Eworuke, Mayura Shinde, Laura Hou, Michael J Paterson, Peter Bjødstrup Jensen, Judith C Maro, Ashish Rai, Daniel Scarnecchia, Dinci Pennap, Daniel Woronow, Rebecca E Ghosh, Stephen Welburn, Anton Pottegard, Robert W Platt, Hana Lee, Marie C Bradley

BMJ Open Apr 2023, 13 (4) e070985; DOI: 10.1136/bmjopen-2022-070985

Main menu

Heart Failure

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Heart Failure

Pages